Page last updated: 2024-11-03

ritanserin and Coma

ritanserin has been researched along with Coma in 1 studies

Ritanserin: A selective and potent serotonin-2 antagonist that is effective in the treatment of a variety of syndromes related to anxiety and depression. The drug also improves the subjective quality of sleep and decreases portal pressure.
ritanserin : A thiazolopyrimidine that is 5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one which is substituted at position 7 by a methyl group and at position 6 by a 2-{4-[bis(4-fluorophenyl)methylidene]piperidin-1-yl}ethyl group. A potent and long-acting seratonin (5-hydroxytryptamine, 5-HT) antagonist of the subtype 5-HT2 (Ki = 0.39 nM), it is used in the treatment of a variety of disorders including anxiety, depression and schizophrenia. It has little sedative action.

Coma: A profound state of unconsciousness associated with depressed cerebral activity from which the individual cannot be aroused. Coma generally occurs when there is dysfunction or injury involving both cerebral hemispheres or the brain stem RETICULAR FORMATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jia, X1
Yan, J1
Xia, J1
Xiong, J1
Wang, T1
Chen, Y1
Qi, A1
Yang, N1
Fan, S1
Ye, J1
Hu, Z1

Other Studies

1 other study available for ritanserin and Coma

ArticleYear
Arousal effects of orexin A on acute alcohol intoxication-induced coma in rats.
    Neuropharmacology, 2012, Volume: 62, Issue:2

    Topics: Alcoholic Intoxication; Animals; Arousal; Benzoxazoles; Brain; Coma; Consciousness; Electroencephalo

2012
chemdatabank.com